Vasopressin in catecholamine-resistant septic and cardiogenic shock in very-low-birthweight infants

Acta Paediatrica, International Journal of Paediatrics

Volumn 95, Issue 10, 2006, Pages 1309-1312

  Meyer, Sascha ^a   Löffler, Günther ^a   Polcher, Thorsten ^a   Gottschling, Sven ^a   Gortner, Ludwig ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Cardiogenic shock; Catecholamine resistant; Septic shock; Vasopressin; Very low birthweight infants

Indexed keywords

VASOPRESSIN;

ANAMNESIS; ARTERIAL PRESSURE; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; HUMAN; NEWBORN; PRIORITY JOURNAL; PROGNOSIS; SEPTIC SHOCK; UNIVERSITY HOSPITAL; VERY LOW BIRTH WEIGHT;

DISEASES IN TWINS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; NOREPINEPHRINE; SHOCK, CARDIOGENIC; SHOCK, SEPTIC; TREATMENT FAILURE; VASOCONSTRICTOR AGENTS; VASOPRESSINS;

EID: 33748859665     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035250500538973     Document Type: Article

References (11)

1. Landry DW, Levin HR, Gallant EM, Ashton RC Jr, Seo S, D'Alessandro D, et al. Vasopressin deficiency contributes to the vasodilatation of septic shock. Circulation 1997;95:1122-5.
2. Rosenzweig EB, Starc TJ, Chen JM, Culliana S, Timchak DM, Gersony WM, et al. Intravenous arginine-vasopressin in children with vasodilatatory shock after cardiac surgery. Circulation 1999;100:II182-6.
3. Masutani S, Senzaki H, Ishido H, Taketazu M, Matsunaga T, Kobayashi T, et al. Vasopressin in the treatment of vasodilatory shock in children. Pediatr Int 2005;47:132-6.
4. Erwin MG, Ross MG, Leake RD, Fisher DA. V1- and V2-receptor contributions to ovine fetal renal and cardiovascular responses to vasopressin. Am J Physiol 1992;262:R636-43.
5. Shi L, Guerra C, Yao J, Xu Z. Vasopressin mechanism-mediated pressor responses caused by central angiotensin II in the ovine fetus. Pediatr Res 2004;56:756-62.
6. Liedel JL, Meadow W, Nachman J, Koogler T, Kahana MD. Use of vasopressin in refractory hypotension in children with vasodilatatory shock: five cases and a review of the literature. Pediatr Crit Care Med 2002;3:15-8.
7. O'Brien A, Clapp L, Singer M. Terlipressin for norepinephrine-resistant septic shock. Lancet 2002;359:1209-10.
8. Tsuneyoshi I, Yamada H, Kakihana Y, Nakamura M, Nakano Y, Boyle WA 3rd. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatatory septic shock. Crit Care Med 2001;29:673-5.
9. Matok I, Leibovitch L, Vardi A, Adam M, Rubinshtein M, Barzilay Z, et al. Terlipressin as a rescue therapy for intractable hypotension during neonatal septic shock. Pediatr Crit Care Med 2004;5:116-8.
10. Matok I, Vard A, Efrati E, Rubinshtein M, Vishne T, Leibovitch L, et al. Terlipressin as a rescue therapy for intractable hypotension due to septic shock in children. Shock 2005;23:305-10.
11. Berg RA. A long-acting vasopressin analog for septic shock: brilliant idea or dangerous folly? Pediatr Crit Care 2004;5:188-9.